{"id":"NCT03734016","sponsor":"BeiGene","briefTitle":"A Study of Zanubrutinib (BGB-3111) Versus Ibrutinib in Participants With Relapsed/Refractory Chronic Lymphocytic Leukemia","officialTitle":"A Phase 3, Randomized Study of Zanubrutinib (BGB-3111) Compared With Ibrutinib in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2018-11-01","primaryCompletion":"2022-08-08","completion":"2024-02-28","firstPosted":"2018-11-07","resultsPosted":"2023-07-27","lastUpdate":"2025-03-30"},"enrollment":652,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Lymphocytic Leukemia","Small Lymphocytic Lymphoma"],"interventions":[{"type":"DRUG","name":"Zanubrutinib","otherNames":["BGB-3111","Brukinsa"]},{"type":"DRUG","name":"Ibrutinib","otherNames":["Imbruvica"]}],"arms":[{"label":"Zanubrutinib","type":"EXPERIMENTAL"},{"label":"Ibrutinib","type":"ACTIVE_COMPARATOR"}],"summary":"This study is designed to compare the overall response rate of zanubrutinib versus ibrutinib in participants with relapsed/refractory chronic lymphocytic leukemia or small lymphocytic lymphoma.","primaryOutcome":{"measure":"Overall Response Rate (ORR) Assessed by the Investigator","timeFrame":"From randomization to the final efficacy analysis cutoff date of 08 August 2022, median time on follow-up was 29.6 months (maximum of 45.2 months).","effectByArm":[{"arm":"Zanubrutinib","deltaMin":83.5,"sd":null},{"arm":"Ibrutinib","deltaMin":74.2,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"},{"comp":"OG000 vs OG001","p":"0.0035"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":115,"countries":["United States","Australia","Belgium","China","Czechia","France","Germany","Italy","Netherlands","New Zealand","Poland","Spain","Sweden","Turkey (TÃ¼rkiye)","United Kingdom"]},"refs":{"pmids":["36511784","36395435","32207333","39853273","39316666","38888616","38502198","38088119","37752892"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":172,"n":324},"commonTop":["COVID-19","Upper respiratory tract infection","Hypertension","Neutropenia","Diarrhoea"]}}